Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Outcomes of Blinatumomab Consolidation in Patients With B-cell Acute Lymphoblastic Leukemia

NCT07117136 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT07117136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07117136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Outcomes of Blinatumomab Consolidation in Patients With B-cell Acute Lymphoblastic Leukemia
Lead sponsor
Medical College of Wisconsin
Phase
Observational
Overall status
Recruiting
Start date
August 28, 2025
Completion date
May 14, 2029
Enrollment
200 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell acute lymphoblastic leukaemia